Filtered By:
Specialty: Cancer & Oncology
Source: Current Oncology
This page shows you your search results in order of relevance. This is page number 2.
Order by Relevance | Date
Total 29 results found since Jan 2013.
Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study
Curr Oncol. 2022 Aug 24;29(9):6077-6090. doi: 10.3390/curroncol29090478.ABSTRACTArterial thromboembolism has been associated with cancer or its treatment. Unlike venous thromboembolism, the incidence and risk factors have not been extensively studied. Here, we investigated the incidence of arterial thromboembolic events (ATEs) in an institutional series of advanced urinary tract cancer (aUTC) treated with cytotoxic chemotherapy. The ATE definition included peripheral arterial embolism/thrombosis, ischemic stroke and coronary events. A total of 354 aUTC patients were analyzed. Most patients (95.2%) received platinum-based c...
Source: Current Oncology - September 22, 2022 Category: Cancer & Oncology Authors: Aristotelis Bamias Kimon Tzannis Roubini Zakopoulou Minas Sakellakis John Dimitriadis Alkistis Papatheodoridi Loukianos Rallidis Panagiotis Halvatsiotis Anna Tsiara Maria Kaparelou Efthymios Kostouros Despina Barbarousi Konstantinos Koutsoukos Evangelos F Source Type: research
Development and pre-testing of a rehabilitation planning consultation for head-and-neck cancer.
CONCLUSIONS: The rpc was feasible to use and satisfactory to a small group of hn cancer survivors. A pilot test of the refined version is in process.
PMID: 28680274 [PubMed - in process]
Source: Current Oncology - July 8, 2017 Category: Cancer & Oncology Tags: Curr Oncol Source Type: research
